Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 50, 1, (1-3), 10.1007/s00259-022-06011-4)

Rudi Dierckx; Ken Herrmann; Roland Hustinx; Michael Lassmann; Wolfgang Wadsak; Jolanta Kunikowska

doi:10.1007/s00259-022-06037-8

Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 50, 1, (1-3), 10.1007/s00259-022-06011-4)

Rudi Dierckx, Ken Herrmann, Roland Hustinx, Michael Lassmann, Wolfgang Wadsak, Jolanta Kunikowska^*

^*Corresponding author for this work

Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE)

Research output: Contribution to journal › Erratum

41 Downloads (Pure)

Abstract

The authors regret that the name of Dr. Michael Lassmann was captured incorrectly as Michael Lassman in the original article.The original article has been corrected.

Original language	English
Pages (from-to)	630
Number of pages	1
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	50
DOIs	https://doi.org/10.1007/s00259-022-06037-8
Publication status	Published - Jan-2023

Access to Document

10.1007/s00259-022-06037-8

Correction Final publisher's version, 368 KBLicence: Taverne

Handle.net

Persistent link

Fingerprint

Dive into the research topics of 'Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 50, 1, (1-3), 10.1007/s00259-022-06011-4)'. Together they form a unique fingerprint.

1 Editorial

European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees
Dierckx, R., Herrmann, K., Hustinx, R., Lassman, M., Wadsak, W. & Kunikowska, J., Dec-2022, In: European Journal of Nuclear Medicine and Molecular Imaging. 50, p. 1-3 3 p.
Research output: Contribution to journal › Editorial › Academic › peer-review

Open Access
File

5 Citations (Scopus)

73 Downloads (Pure)

Cite this

Dierckx, R., Herrmann, K., Hustinx, R., Lassmann, M., Wadsak, W., & Kunikowska, J. (2023). Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 50, 1, (1-3), 10.1007/s00259-022-06011-4). European Journal of Nuclear Medicine and Molecular Imaging, 50, 630. https://doi.org/10.1007/s00259-022-06037-8

Dierckx, Rudi ; Herrmann, Ken ; Hustinx, Roland et al. / Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 50, 1, (1-3), 10.1007/s00259-022-06011-4). In: European Journal of Nuclear Medicine and Molecular Imaging. 2023 ; Vol. 50. pp. 630.

@article{1a93935c27ff4423a44a6c1e1b8e495f,

title = "Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO{\textquoteright}s framework for radiopharmaceutical therapy curriculum development for trainees (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 50, 1, (1-3), 10.1007/s00259-022-06011-4)",

abstract = "The authors regret that the name of Dr. Michael Lassmann was captured incorrectly as Michael Lassman in the original article.The original article has been corrected.",

author = "Rudi Dierckx and Ken Herrmann and Roland Hustinx and Michael Lassmann and Wolfgang Wadsak and Jolanta Kunikowska",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022.",

year = "2023",

month = jan,

doi = "10.1007/s00259-022-06037-8",

language = "English",

volume = "50",

pages = "630",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer",

}

Dierckx, R, Herrmann, K, Hustinx, R, Lassmann, M, Wadsak, W & Kunikowska, J 2023, 'Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 50, 1, (1-3), 10.1007/s00259-022-06011-4)', European Journal of Nuclear Medicine and Molecular Imaging, vol. 50, pp. 630. https://doi.org/10.1007/s00259-022-06037-8

Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 50, 1, (1-3), 10.1007/s00259-022-06011-4). / Dierckx, Rudi; Herrmann, Ken; Hustinx, Roland et al.
In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, 01.2023, p. 630.

Research output: Contribution to journal › Erratum

TY - JOUR

T1 - Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 50, 1, (1-3), 10.1007/s00259-022-06011-4)

AU - Dierckx, Rudi

AU - Herrmann, Ken

AU - Hustinx, Roland

AU - Lassmann, Michael

AU - Wadsak, Wolfgang

AU - Kunikowska, Jolanta

N1 - Publisher Copyright: © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022.

PY - 2023/1

Y1 - 2023/1

N2 - The authors regret that the name of Dr. Michael Lassmann was captured incorrectly as Michael Lassman in the original article.The original article has been corrected.

AB - The authors regret that the name of Dr. Michael Lassmann was captured incorrectly as Michael Lassman in the original article.The original article has been corrected.

U2 - 10.1007/s00259-022-06037-8

DO - 10.1007/s00259-022-06037-8

M3 - Erratum

C2 - 36374354

AN - SCOPUS:85141947146

SN - 1619-7070

VL - 50

SP - 630

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

ER -

Dierckx R, Herrmann K, Hustinx R, Lassmann M, Wadsak W, Kunikowska J. Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 50, 1, (1-3), 10.1007/s00259-022-06011-4). European Journal of Nuclear Medicine and Molecular Imaging. 2023 Jan;50:630. doi: 10.1007/s00259-022-06037-8